A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2
Clinical trial NCT06039449 · COMPLETED
Trial details
- NCT number
- NCT06039449
- Sponsor
- Invivyd, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-08
- Primary completion
- 2024-11-19
- Enrollment
- 790
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.